What if the medication you take to strengthen your bones could set you up for catastrophic bone density loss in the future? It may seem counterintuitive, but my recent research has revealed an uncomfortable truth about one of the most popular osteoporosis medications. For years, we’ve focused on the immediate benefits of these drugs, but it’s important to understand the long-term game plan. What happens when you want or need to stop taking it? The answer may not only surprise you, but it may fundamentally change the way you approach your bone health strategy.
Today, we’ll take a deep dive into the world of osteoporosis treatments, specifically a drug called denosumab, sold under the brand name Prolia. Although it shows impressive results in the short term, the consequences of stopping it can be severe, leading to a rapid rebound in bone loss that may leave you worse off than when you started. My goal is to provide you with the information you need to have an informed conversation with your doctor. It’s not about being afraid of medication, it’s about choosing the right path for your unique condition and making sure you have a safe and effective strategy for the decades to come. (Based on insights from Dr. Doug Lucas)
Key takeaways
- Brolia’s paradox: While Prolia (denosumab) is very effective at increasing bone density and reducing the risk of fractures while taking it, it does come with a major advantage.
- Bounce effect: Stopping taking Prolia can result in rapid and severe bone loss, often wiping out all gains and even increasing the risk of fractures to a higher level than it was before treatment.
- Chaos sign bone: After stopping the drug, markers of bone breakdown (CTX) can rise 100-200% above your baseline, while markers of bone synthesis (P1NP) see only a modest increase, creating a state of rapid bone destruction.
- There is no easy way out: You cannot simply stop taking Prolia. Stopping smoking requires a carefully managed and monitored plan, which usually includes switching to another type of osteoporosis medication to prevent a dangerous rebound effect.
- Make informed decisions: Understanding the long-term adherence and difficulty of stopping Prolia is essential before starting treatment. There may be other options that align better with your long-term health goals.
1. What is Prolia (denosumab) and how does it work?
First, let’s understand what Prolia is. Denosumab is a powerful drug approved for treatment Osteoporosis. It works by targeting a specific pathway in your body to prevent the formation of cells called osteocytes. Think of bone cells as a demolition crew for your bones; It is responsible for breaking down old bone tissue. By blocking it, Prolia acts as a powerful “anti-resorptive” agent, meaning it dramatically slows the rate of bone loss.
On paper, the results are great. The landmark FREEDOM trial showed that over three years, patients taking Prolia saw bone mineral density increase by an impressive 9% in the spine and 6% in the hips. Most importantly, this led to a significant reduction in fractures: a 68% reduction in new spine fractures and a 40% reduction in hip fractures. With numbers like these, it’s easy to see why it has become a popular choice for doctors and patients alike. Sounds like a home run for bone health.
2. Early warning signs: A look at the signs of bone turnover
This is where the story gets more complicated. To really understand what a drug does, we can look at something called bone turnover markers (BTMs). These are substances in your blood that tell us how much bone is being built and how much is being broken down. The two main players are P1NP, which is a marker for bone formationand CTX, a marker for bone Sipping (separation). In a healthy state, these two processes are coupled and balanced.
When you take Prolia, it upsets this balance. Within the first month of injections, your CTX levels can drop by more than 86%. Your demolition crew has almost completely shut down. The bone building marker, P1NP, also decreases, but much more slowly, eventually stabilizing at a level of inhibition of about 76% after three years. The problem is that your body is now in a very low state of rotation. While this prevents bone loss, it also hinders the natural process of repairing and replacing old bone with healthy new bone. This deep repression is the first clue that something dramatic might happen if this repression were suddenly removed.
3. The long-term picture: What does ten years on Prolia look like?
So, what happens if you stay on the medication for a long time? The FREEDOM Extension trial followed patients for up to 10 years. The results continued to look good on the surface. Bone mineral density continued to rise, reaching a significant increase of 22% at the spine and 9% at the hip over the decade. The rate of new fractures remained low.
However, this is also when we begin to see rare but serious side effects associated with severe, long-term suppression of bone turnover. These include osteonecrosis of the jaw (ONJ) and atypical femur fractures, which are bizarre fractures that can occur in the thigh bone with little or no trauma. Although it is still very rare, its occurrence is a direct result of suppression of the normal bone remodeling process for too long. Unlike other medications such as bisphosphonates, which recommend a “drug holiday” after 3-5 years, guidelines for Prolia do not have a specific stopping point. The reason for this is what we will discuss next, which is the crux of the problem.
4. Rebound effect: the real danger of stopping Prolia
This is the crucial issue that makes Prolia probably the worst osteoporosis drug in my book. When you stop taking it, you don’t just go back to where you started. You could end up in a more dangerous place. This is known as the “rebound effect.” Research analyzing what happens after patients stop treatment reveals three concerning things:
- Low bone density: All the wonderful gains you’ve made in bone density are wiped out incredibly quickly. Within 12 to 24 months of the last injection, your BMD usually returns to its pre-treatment baseline and, in many cases, drops below that.
- High risk of fracture: Your risk of fracture is not just due to normal; It actually goes up. Studies show a significant and, even more alarmingly, increased risk of single vertebral fractures after stopping Prolia. You have lost your protection and are now more vulnerable than before.
- Bone signs get stuck: BTMs tell the whole story. After stopping, CTX (a marker of bone breakdown) goes to higher levels, rising to more than 100%, sometimes even 200%, above the original baseline. At the same time, P1NP (a bone building marker) increases by a modest 30-50%. Imagine your demolition crew is coming back strong, but your construction crew is understaffed and can’t keep up. You are in a rapid free fall of bone loss.
5. Why can’t you just “come off” this medication?
This rebound phenomenon is why you should never stop taking Prolia and hope for the best. Burying your head in the sand is a recipe for disaster. A massive and uncontrolled rise in bone breakdown creates a period of extreme vulnerability to fractures. For this reason, quitting drugs is a complex medical process.
This must be done in a highly organized and closely monitored manner. The current strategy involves immediately switching from Prolia to another anti-resorptive medication, usually a bisphosphonate such as Reclast (zoledronic acid). The goal is to use the second drug to “catch” the bone and prevent the CTX from rising too high, essentially taming the rebound effect. This means that if you start Prolia, you are either committed to taking it indefinitely or committed to a multidrug sequence. This is a serious consideration in the long term, and not always clearly expressed upfront.
6. Ranking of options: Where does Prolia stand now?
Given this new understanding, I had to reevaluate how I categorized osteoporosis medications for my patients, especially for those who didn’t want to be on medication forever. For me, Brolia is now at the bottom of the list.
My preferred approach, for those good candidates, starts with stimulant medications like Forteo or Timlos. These medications are active Builds New bones and works synergistically with lifestyle and hormone optimization. After that, I now put on bisphosphonates. Although I used to be more critical, their effects are more predictable, and you can safely take a “drug holiday” after a few years. The rebound effect is not a concern with these medications. Prolia, due to its difficult and risky exit strategy, is now my last option. It may have a time and place for certain individuals, but the decision to start should come with the full knowledge that it is a long-term, perhaps permanent, commitment.
conclusion
Your bone health is a lifelong journey, and the choices you make today will impact your strength and independence for decades. Prolia can deliver impressive gains in the short term, but it comes with a serious liability in the long term. The potential for rapid recovery and serious bone loss when discontinued makes it an option that should not be taken lightly. Please, use this information to have a detailed conversation with your doctor. Ask about the long-term plan. Ask what happens if you need to stop. Your health is more than just your bone density score; It’s about staying strong, making memories, and aging strong and graceful.
source: Dr. Doug Lucas
